Search

everythinglearnresearchcommunity

for

Search:↓

High-quality data on skin cancer is crucial for understanding its trends and allocating healthcare resources effectively.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

Both Billroth-I and Billroth-II methods have similar impacts on quality of life after gastric cancer surgery.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Living near more dermatologists and using certain cancer screening tests lowers the chance of being diagnosed with advanced skin cancer.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Most U.S. keratinocyte carcinoma patients are older white males living in urban areas.

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Lifestyle factors like BMI at young adulthood can increase cancer risk in women with Lynch Syndrome, but diet and height don't seem to affect this risk.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Early balding at 40 increases prostate cancer risk.

Finasteride use may increase the risk of male breast cancer.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.